Investors

A pharmaceutical drug developer with a strong investment case

Share capital development

YearTransactionChange in number of sharesChange in share capital (SEK)Total number of sharesTotal share capital (SEK)Quota value per share (SEK)    
2006Formation100 000100 000100 000100 0001,00
2007New issue88 00088 000188 000188 0001,00
2008New issue18 80018 800206 800206 8001,00
2009New issue25 85025 850232 650232 6501,00
2010New issue68 66668 666301 316301 3161,00
2011Bonus issue-301 316301 316602 6322,00
2011New issue46 81393 626348 129696 2582,00
2011Split12 880 773-13 228 902696 2580,05
2011New issue7 018 873369 41420 247 7751 065 6720,05
2013New issue1 687 31488 80621 935 0891 154 4780,05
2014New issue1 687 31488 80623 622 4031 243 2840,05
2014New issue4 724 480248 65728 346 8831 491 9410,05
2015New issue/Warrants42 0002 21128 388 8831 494 1520,05
2016New issue20 277 7731 067 25248 666 6562 561 4040,05
No share-related financial instruments are outstanding after April 15, 2015.

Calendar and upcoming reports

7 January 2019
JPM week

21 February 2019
Year end report 2018

Show more events

Share

Facebook
Twitter
LinkedIn
RSS

Contact us

Address: Grev Turegatan 11 C, 114 46 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@pledpharma.com